(Q48360766)

11 February 2018

title

Perfadex for clinical lung procurement: is it an advance? (English)

1 reference

11 February 2018

author name string

Tarek M Aziz

1

1 reference

11 February 2018

Thaseegaran M Pillay

2

1 reference

11 February 2018

Paul A Corris

3

1 reference

11 February 2018

Jonathan Forty

4

1 reference

11 February 2018

Colin J Hilton

5

1 reference

11 February 2018

Asif Hasan

6

1 reference

11 February 2018

John H Dark

7

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 March 2003

1 reference

11 February 2018

The Annals of Thoracic Surgery

published in

1 reference

11 February 2018

volume

75

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

990-995

1 reference

11 February 2018

Eliminating the strong pulmonary vasoconstriction caused by Euro-Collins solution

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Pulmonary vascular resistance related to endothelial function after lung transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Successful canine bilateral single-lung transplantation after 21-hour lung preservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Safe pulmonary preservation for 12 hours with low-potassium-dextran solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Experience with lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

High potassium contents in organ preservation solutions cause strong pulmonary vasocontraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Perfadex is superior to Euro-Collins solution regarding 24-hour preservation of vascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

The superiority of an extracellular fluid solution over Euro-Collins' solution for pulmonary preservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Acellular low-potassium dextran preserves pulmonary function after 48 hours of ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Influence of preservation solution on early graft failure in clinical lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

Low-potassium dextran preservation solution improves lung function after human lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904491-0

10.1016/S0003-4975(02)04491-0

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018